Patents/Inventors

Matthew During

Darien, CTUS10 patents

12 Patents

US124655972025
Methods of Treating Developmental Disorders with Gaboxadol
OVID THERAPEUTICS Inc.
0 cites
US122853972025
Use of (s)-3-amino-4-(difluoromethylenyl) Cyclopent-1-ene-1-carboxylic Acid and Related Compounds, (1s,3s)-3-amino-4-(difluoromethylidene) Cyclopentane-1-carboxylic Acid and Vigabatrin in the Treatment of Developmental Disorders
OVID THERAPEUTICS Inc.
0 cites
US121448012024
Methods and Compositions for Treatment of Epileptic Disorders
OVID THERAPEUTICS Inc.
0 cites
US121092012024
Methods and Compositions for Treatment of Epileptic Disorders
Ovid Therapeutics Inc.
0 cites
US119185512024
Methods of Treating Seizure Disorders and Prader-willi Syndrome
OVID THERAPEUTICS Inc.
0 cites
US119185632024
Methods and Compositions for Treatment of Epileptic Disorders
Ovid Therapeutics Inc.
0 cites
US119039302024
Methods and Compositions for Treatment of Epileptic Disorders
Ovid Therapeutics Inc.
0 cites
US118063362023
Methods and Compositions for Treatment of Epileptic Disorders
OVID THERAPEUTICS Inc.
0 cites
US117716712023
Use of (1s,3s)-3-amino-4-(difluoromethylidene) Cyclopentane-1-carboxylic Acid and (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid in the Treatment of Tinnitus, Acute Sensorineural Hearing Loss, Meniere's Disease, Tourette's Syndrome, Attention Deficit Hyperactivity Disorder and Addiction
Ovid Therapeutics Inc.
0 cites
US117610062023
Use of MIR101 or MIR128 in the Treatment of Seizure Disorders
Ovid Therapeutics Inc.
0 cites
US116908292023
Use of Gaboxadol for the Treatment of Non-24 Hour Sleep-wake Disorder
Ovid Therapeutics Inc.
0 cites
US116602772023
Use of (s)-3-amino-4-(difluoromethylenyl) Cyclopent-1-ene-1-carboxylic Acid and Related Compounds, (1s,3s)-3-amino-4-(difluoromethylidene) Cyclopentane-1-carboxylic Acid and Vigabatrin in the Treatment of Developmental Disorders
Ovid Therapeutics Inc.
0 cites